Our approach to
CORPORATE RESPONSIBILITY
Our responsibility strategy uses Regeneron’s unique knowledge and expertise to address the issues that matter most to our business and our stakeholders. Guided by our corporate philosophy of “Doing Well by Doing Good,” our approach spans three strategic focus areas: improving the lives of people with serious diseases, fostering a culture of integrity and excellence, and building sustainable communities.
Our responsibility goals
Regeneron’s 2025 responsibility goals reflect our mission to bring important new medicines to people with serious diseases. We engaged stakeholders and used leading corporate responsibility frameworks, including the United Nations Sustainable Development Goals (SDGs), to help guide the development of our 12 responsibility goals and accompanying environmental targets.
- Use the power of science to discover and advance important new medicines while continuing to make substantial investments into R&D.
- Identify genetic insights that will support the discovery and advancement to tomorrow's medicines through our Regeneron Genetics Center®.
- Support organizations that offer disease prevention, diagnosis and treatment for people touched by serious diseases.
- Set fair, value-based prices for our medicines and break down barriers to patient access.
- Cultivate a leading employee experience that is rooted in our unique science-driven culture.
- Increase representation of diverse individuals in leadership and foster inclusion across our organization.
- Be vigilant in ensuring integrity remains at the core of how we operate.
- Implement continuous improvements to uphold our high-quality, safe and reliable product supply.
- Make Regeneron the safest part of people’s day by focusing on prevention in our drive towards zero incidents.
- Drive employee volunteer levels above standards.
- Foster the next generation of scientific innovators by providing STEM experiences to 2.5 million students.
- Achieve our environmental targets to help protect and restore the planet.
Transparency and policies
Learn about our efforts to increase accountability and transparency at Regeneron.
Operational oversight
Regeneron’s Board of Directors’ Corporate Governance and Compliance Committee oversees corporate responsibility and reviews progress against our responsibility strategy at least once a year. At the management level, our Responsibility Committee, composed of cross-functional leaders, is accountable for our responsibility strategy, goals and metrics.
A Compliance Program With Science and Patients at the Core
When your motivation is advancing science and helping as many people as possible, ethics and integrity come naturally.
Innovating for Good
Applying a toddler’s mindset to build resiliency and improve our world
Advancing African Ancestry Representation in Genomic Research and STEM Education
Driven to make a difference through the Together for CHANGE™ Initiative
Our progress is being recognized
Dow Jones:
Sustainability World Index, 2023
Dow Jones:
Sustainability North America Index, 2023
Civic 50:
List of most community-minded companies in the U.S., 2024
ISS ESG:
Top 10% in industry*
Newsweek:
America’s Most Responsible Companies, 2024
Human Rights Campaign:
Corporate Equality Index, 2023
Disability:IN:
Disability Equality Index, 2024
S&P Global:
Top 1% in industry*
Sustainalytics:
Top 2% in industry*
*As of December 2023